Bovine Colostrum for Preterm Newborns
NCT03085277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350
Last updated 2022-07-12
Summary
Feeding intolerance is a common problem in very preterm infants due to their immature digestive system. This intolerance extends the time to full enteral feeding and thereby also prolongs the time on parenteral nutrition (PN). Prolonged time to full enteral feeding may predispose these infants to a higher risk of growth retardation, infections and organ dysfunctions (e.g. liver, brain). Mother's own milk (MM) is considered the optimal nutrition for preterm infants and is superior to infant formula (including preterm formula, PF) in stimulating gut maturation, feeding tolerance, resistance against necrotizing enterocolitis (NEC) and late-onset sepsis (LOS), and long-term neurodevelopmental outcomes. However, MM is often absent, or not available in sufficient amounts, during the first days or weeks after preterm delivery. Human donor milk (DM) is probably a better supplement to MM than PF, but DM is not available for all hospitals. To supplement insufficient MM during the early neonatal period in hospital settings with no access to donor milk, we suggest that bovine colostrum (BC) may be used instead of PF for very preterm infants during early life. BC, the first milk from cows after birth, is a rich source of protein and bioactive components, including lactoferrin, lysozyme, lactoperoxidase, immunoglobulins, and various growth factors, such as IGF-I and -II, EGFs, and TGF-β. BC has repeatedly been shown to improve gut maturation and NEC/LOS resistance in a well-established piglet model of preterm infants. We suggest a randomized, controlled trial to investigate the effects of BC vs. PF, supplemented to MM during the first 2 weeks, on the time to full enteral feeding in very preterm infants.
Conditions
- Enteral Feeding Intolerance
- Necrotizing Enterocolitis
- Late-Onset Neonatal Sepsis
Interventions
- DIETARY_SUPPLEMENT
-
Bovine Colostrum
Bovine colostrum (BC) is the first milk from cows after birth and we suggest that BC may be used to supplement MM, instead of infant formula or DM. BC is a rich source of protein (up to 150 g/L) and bioactive components, including lactoferrin, lysozyme, lactoperoxidase, immunoglobulins, and various growth factors, such as, IGF-I and -II, EGFs, and TGF-β. BC has repeatedly been shown to have beneficial effects in a well-established piglet model of preterm infants, using various feeding regimens, including a gradual regimen that would mimic enteral feeding for preterm infants without access to MM during the first week.
- DIETARY_SUPPLEMENT
-
Preterm Formula
Preterm formula is a type of infant formula designed for preterm infants. It is used when mother's own milk is not available or not in sufficient amount as the enteral feeding for preterm infants in hospitals that do not have donor human milk.
Sponsors & Collaborators
-
Sixth Affiliated Hospital, Sun Yat-sen University
collaborator OTHER -
Maternal and Child Health Hospital of Foshan
collaborator OTHER -
Shenzhen People's Hospital
collaborator OTHER -
Shenzhen Luohu Maternal and Child Health Hospital
collaborator UNKNOWN -
University of Chinese Academy of Sciences - Shenzhen Hospital
collaborator UNKNOWN -
Longgang District People's Hospital of Shenzhen
collaborator OTHER -
Shenzhen Nanshan Maternity and Child Healthcare Hospital
collaborator UNKNOWN -
Dongguan Women and Children's Hospital
collaborator UNKNOWN -
Per Torp Sangild
lead OTHER
Principal Investigators
-
Per Sangild, PhD · University of Copenhagen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Max Age
- 2 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-01
- Primary Completion
- 2020-10-23
- Completion
- 2020-11-18
Countries
- China
Study Locations
More Related Trials
-
Bovine Colostrum in Prevention of Necrotizing Enterocolitis and Sepsis in Very Low Birth Weight Neonates
NCT04886674 ·Status: UNKNOWN
-
Impact of Colostrum Oropharyngeal Immunotherapy on Postnatal Growth in Preterm Infants
NCT07082881 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Protocol for Feeding Intolerance in Preterm Infants
NCT05347706 ·Status: UNKNOWN ·Phase: NA
-
Feeding Tolerance in Preterm Infants
NCT00450697 ·Status: UNKNOWN
-
Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum
NCT05481866 ·Status: UNKNOWN ·Phase: NA
-
Early Versus Delayed Feeding in Preterm Growth-Restricted Infants
NCT03443297 ·Status: UNKNOWN ·Phase: NA
-
Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight Infants
NCT00005888 ·Status: COMPLETED ·Phase: NA
-
Oral Care With Colostrum for Preventing Late-onset Sepsis in Preterm Infants
NCT06534632 ·Status: COMPLETED ·Phase: NA
-
Nutrition and Growth in Very Preterm Infants
NCT04143204 ·Status: COMPLETED
-
Gastrointestinal Tolerance And General Health Status Of Healthy Term Infants Fed A New Infant Formula
NCT01370967 ·Status: COMPLETED
-
Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants
NCT02073071 ·Status: COMPLETED
-
Speed of Increasing Milk Feeds Trial
NCT01727609 ·Status: COMPLETED ·Phase: NA
-
Enrichment of Human Milk With Human and Bovine Milk-based Fortifiers for Very Preterm Infants: a Meta-analysis
NCT06870318 ·Status: COMPLETED
-
To Investigate Effects of a New Infant Formula in Healthy Term Chinese Infants
NCT03520764 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of the Feasibility of Feeding Preterm Infants With Fresh Versus Frozen Mother's Own Breast Milk in the NICU
NCT03258957 ·Status: COMPLETED ·Phase: NA
-
Exclusive Enteral Nutrition in Preterm Neonates
NCT04337710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Effects of a Formula With Modified Protein Levels and Fat Blend in Preterm Infants
NCT03055052 ·Status: COMPLETED ·Phase: NA
-
The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies
NCT06072976 ·Status: RECRUITING ·Phase: NA
-
Targeted vs Standard Fortification of Breast Milk
NCT03775785 ·Status: UNKNOWN ·Phase: NA
-
Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants
NCT04284280 ·Status: COMPLETED ·Phase: NA
-
Preterm Infant Growth
NCT01162798 ·Status: COMPLETED ·Phase: NA
-
The Effect of a New Infant Formula on Growth and Cognition in Healthy Term Infants
NCT04508257 ·Status: UNKNOWN ·Phase: NA
-
Early Exclusive Enteral Nutrition in Early Preterm Infants
NCT03708068 ·Status: COMPLETED ·Phase: NA
-
Effect of Increased Enteral Protein on Body Composition of Preterm Infants
NCT03586102 ·Status: COMPLETED ·Phase: NA
-
An Infant Formula Trial on Dietary Management of Infantile Colic
NCT03329222 ·Status: TERMINATED ·Phase: NA